Seo Jung-jin
Networth: 6 Billion
Country: South Korea
Industry: Healthcare
Seo Jung-jin is cofounder of Celltrion, a biopharmaceutical firm that makes drugs to treat cancer, influenza and rheumatoid arthritis, among others.With the success of biosimilars in South Korea, his Celltrion has become a favorite among investors. In March 2021, Seo stepped down as chairman of the Celltrion group.Seo's eldest son Jin-seok now chairs Celltrion Inc. and Celltrion Pharm while his other son Joon-serk chairs Celltrion Healthcare.Seo started Celltrion Inc. in 2002 and took it public in 2008.
Financial Assets
Ticker: 091990-KR
Shares: 55,428,700
Ticker: 068270-KR
Shares: 28,904,000